These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21249601)

  • 1. Thyroid disorders and hypercoagulability.
    Erem C
    Semin Thromb Hemost; 2011 Feb; 37(1):17-26. PubMed ID: 21249601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid dysfunction and hemostasis: an issue still unresolved.
    Franchini M; Montagnana M; Manzato F; Vescovi PP
    Semin Thromb Hemost; 2009 Apr; 35(3):288-94. PubMed ID: 19452404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation and fibrinolysis in thyroid dysfunction.
    Erem C
    Endocrine; 2009 Aug; 36(1):110-8. PubMed ID: 19367377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The spectrum of coagulation abnormalities in thyroid disorders.
    Vescovi PP; Favaloro EJ; Lippi G; Garofano M; Montagnana M; Manzato F; Franchini M
    Semin Thromb Hemost; 2011 Feb; 37(1):7-10. PubMed ID: 21249600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thyroid and hemostasis].
    Franchini M
    Recenti Prog Med; 2006 May; 97(5):267-71. PubMed ID: 16838559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemostatic changes in thyroid diseases: haemostasis and thrombosis.
    Franchini M
    Hematology; 2006 Jun; 11(3):203-8. PubMed ID: 17325963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Disorders of hemostasis in dysthyroidism].
    Klein M; Barbé F; Kaminsky P; Duc M
    Pathol Biol (Paris); 1993 Mar; 41(3):268-75. PubMed ID: 8332397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of acquired von Willebrand's syndrome in patients with thyroid diseases undergoing thyroid surgery.
    Franchini M; Zugni C; Veneri D; Gandini G; Lippi G; Manzato F; Brazzarola P
    Haematologica; 2004 Nov; 89(11):1341-6. PubMed ID: 15531456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemostasis and thyroid diseases revisited.
    Franchini M
    J Endocrinol Invest; 2004 Oct; 27(9):886-92. PubMed ID: 15648557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism.
    Erem C; Ucuncu O; Yilmaz M; Kocak M; Nuhoglu I; Ersoz HO
    Endocrine; 2009 Feb; 35(1):75-80. PubMed ID: 18958631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid disorders and hypocoagulability.
    Marongiu F; Barcellona D; Mameli A; Mariotti S
    Semin Thromb Hemost; 2011 Feb; 37(1):11-6. PubMed ID: 21305799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of thyroid function on the coagulation system and its clinical consequences.
    Elbers LPB; Fliers E; Cannegieter SC
    J Thromb Haemost; 2018 Apr; 16(4):634-645. PubMed ID: 29573126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical review: Thyroid dysfunction and effects on coagulation and fibrinolysis: a systematic review.
    Squizzato A; Romualdi E; Büller HR; Gerdes VE
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2415-20. PubMed ID: 17440013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: coagulation disorders in chronic liver disease.
    Peck-Radosavljevic M
    Aliment Pharmacol Ther; 2007 Nov; 26 Suppl 1():21-8. PubMed ID: 17958516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation in hepatobiliary disease.
    Kavanagh C; Shaw S; Webster CR
    J Vet Emerg Crit Care (San Antonio); 2011 Dec; 21(6):589-604. PubMed ID: 22316251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and subclinical thyroid disorders associated with pernicious anemia. Observations on abnormal thyroid-stimulating hormone levels and on a possible association of blood group O with hyperthyroidism.
    Carmel R; Spencer CA
    Arch Intern Med; 1982 Aug; 142(8):1465-9. PubMed ID: 7103627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment.
    Lisman T; Leebeek FW
    Dig Surg; 2007; 24(4):250-8. PubMed ID: 17657149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemostasis in Overt and Subclinical Hyperthyroidism.
    Ordookhani A; Burman KD
    Int J Endocrinol Metab; 2017 Jul; 15(3):e44157. PubMed ID: 29201071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemostasis in Hypothyroidism and Autoimmune Thyroid Disorders.
    Ordookhani A; Burman KD
    Int J Endocrinol Metab; 2017 Apr; 15(2):e42649. PubMed ID: 29026409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.